ZyVersa Therapeutics, Inc. is a clinical-stage specialty biopharmaceutical company. The Company is focused on leveraging advanced technologies to develop drugs for patients with chronic renal or inflammatory diseases. Its development pipeline include... Read more
Access detailed stock analysis from LSEG including analyst price target estimates.